Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2019

Open Access 01-12-2019 | Schizophrenia | Research article

Exploring the potential cost-effectiveness of a vocational rehabilitation program for individuals with schizophrenia in a high-income welfare society

Authors: Stig Evensen, Torbjørn Wisløff, June Ullevoldsæter Lystad, Helen Bull, Egil W. Martinsen, Torill Ueland, Erik Falkum

Published in: BMC Psychiatry | Issue 1/2019

Login to get access

Abstract

Background

Over the past decades research has shown that employment has a positive impact on quality of life, global functioning and recovery in individuals with schizophrenia. However, access to vocational rehabilitation services for this group is limited and unemployment rates remain high. In this study we explore the potential cost-effectiveness of a novel vocational rehabilitation program (The Job Management Program – JUMP) earmarked for individuals with schizophrenia in Norway.

Methods

The JUMP study was a vocational rehabilitation program augmented with either cognitive behaviour therapy or cognitive remediation. In addition to the JUMP protocol, we extracted treatment cost data from comprehensive and mandatory health and welfare registers. The costs over a two-year follow-up period were compared with the costs over the two-year period prior to inclusion in the study. We also compared the cost-effectiveness of JUMP with a treatment as usual group (TAU).

Results

We identified significant reductions in inpatient services in the JUMP group, both for those who obtained employment and those who did not. Significant reductions were also found in the TAU group, but adjusted for baseline differences the total cost for JUMP participants were € 10,621 lower than in the TAU group during the follow-up period.

Conclusion

In addition to supporting individuals with schizophrenia obtain employment, JUMP appears to have reduced the reliance on mental health services, which should be of interest to stakeholders.

Trial registration

ClinicalTrials.gov Identifier: NCT01139502. Retrospectively registered on 6 February 2010.
Literature
1.
McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A. Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial. Am J Psychiatry. 2007;164(3):437–41.PubMed
2.
Alonso J, Croudace T, Brown J, Gasquet I, Knapp MR, Suarez D, Novick D. Health-related quality of life (HRQL) and continuous antipsychotic treatment: 3-year results from the schizophrenia health outcomes (SOHO) study. Value Health. 2009;12(4):536–43.PubMed
3.
Bouwmans C, de Sonneville C, Mulder CL, Hakkaart-van Roijen L. Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatr Dis Treat. 2015;11:2125–42.PubMedPubMedCentral
4.
Burns T, Catty J, White S, Becker T, Koletsi M, Fioritti A, Rossler W, Tomov T, van Busschbach J, Wiersma D, et al. The impact of supported employment and working on clinical and social functioning: results of an international study of individual placement and support. Schizophr Bull. 2009;35(5):949–58.PubMed
5.
Jonsdottir A, Waghorn G. Psychiatric disorders and labour force activity. Ment Health Rev J. 2015;20(1):13.
6.
Davidson M, Kapara O, Goldberg S, Yoffe R, Noy S, Weiser M. A nation-wide study on the percentage of schizophrenia and bipolar disorder patients who earn minimum wage or above. Schizophr Bull. 2015;42:443–7.PubMedPubMedCentral
7.
Evensen S, Wisloff T, Lystad JU, Bull H, Ueland T, Falkum E. Prevalence, employment rate, and cost of schizophrenia in a high-income welfare society: a population-based study using comprehensive health and welfare registers. Schizophr Bull. 2016;42(2):476–83.PubMed
8.
OECD: Mental Health and Work: Norway. In.; 2013.
9.
Burns T, White SJ, Catty J. Individual placement and support in Europe: the EQOLISE trial. Int Rev Psychiatry. 2008;20(6):498–502.PubMed
10.
Bond GR, Drake RE. Making the case for IPS supported employment. Admin Pol Ment Health. 2014;41(1):69–73.
11.
Bond GR, Drake RE, Becker DR. An update on randomized controlled trials of evidence-based supported employment. Psychiatr Rehabil J. 2008;31(4):280–90.PubMed
12.
Bond GR, Drake RE, Campbell K. Effectiveness of individual placement and support supported employment for young adults. Early Interv Psychiatry. 2014.
13.
Burns T, Catty J, Becker T, Drake RE, Fioritti A, Knapp M, Lauber C, Rossler W, Tomov T, van Busschbach J, et al. The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial. Lancet. 2007;370(9593):1146–52.PubMed
14.
Mueser KT, Becker DR, Torrey WC, Xie H, Bond GR, Drake RE, Dain BJ. Work and nonvocational domains of functioning in persons with severe mental illness: a longitudinal analysis. J Nerv Ment Dis. 1997;185(7):419–26.PubMed
15.
Luciano A, Bond GR, Drake RE. Does employment alter the course and outcome of schizophrenia and other severe mental illnesses? A systematic review of longitudinal research. Schizophr Res. 2014;159(2–3):312–21.PubMed
16.
Evensen S, Ueland T, Lystad JU, Bull H, Klungsoyr O, Martinsen EW, Falkum E. Employment outcome and predictors of competitive employment at 2-year follow-up of a vocational rehabilitation programme for individuals with schizophrenia in a high-income welfare society. Nord J Psychiatry. 2017;71(3):180–7.PubMed
17.
Marino LA, Dixon LB. An update on supported employment for people with severe mental illness. Curr Opin Psychiatry. 2014;27(3):210–5.PubMedPubMedCentral
18.
Salkever D. Social costs of expanding access to evidence-based supported employment: concepts and interpretive review of evidence. Psychiatr Serv. 2013;64(2):111–9.PubMed
19.
Knapp M, Patel A, Curran C, Latimer E, Catty J, Becker T, Drake RE, Fioritti A, Kilian R, Lauber C, et al. Supported employment: cost-effectiveness across six European sites. World Psychiatry. 2013;12(1):60–8.PubMedPubMedCentral
20.
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated health economic evaluation reporting standards (CHEERS)--explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16(2):231–50.PubMed
21.
Spjelkavik Ø. Supported employment in Norway and in the other Nordic countries. J Vocational Rehabil. 2012;37:163–72.
22.
Falkum E, Klungsøyr O, Lystad JU, Bull HC, Evensen S, Martinsen E, Friis S, Ueland T. Vocational rehabilitation for adults with psychotic disorders in a Scandinavian welfare society. BMC Psychiatry. 2017:17, 24.
23.
Lystad JU, Falkum E, Haaland VO, Bull H, Evensen S, McGurk SR, Ueland T. Cognitive remediation and occupational outcome in schizophrenia spectrum disorders: a 2year follow-up study. Schizophr Res. 2017;185:122–9.PubMed
24.
Lystad JU, Falkum E, Haaland VO, Bull H, Evensen S, Bell MD, Ueland T. Neurocognition and occupational functioning in schizophrenia spectrum disorders: the MATRICS consensus cognitive battery (MCCB) and workplace assessments. Schizophr Res. 2016;170(1):143–9.PubMed
25.
APA: Diagnostic and statistical manual of mental disorders: DSM-IV; 1994.
26.
Bull H, Ueland T, Lystad JU, Evensen S, Friis S, Martinsen EW, Falkum E. Validation of the work behavior inventory. Nord J Psychiatry. 2015;69(4):300–6.PubMed
27.
Berge T, Falkum E. Se mulighetene: Arbeidsliv og psykisk helse. Oslo: Gyldendal Akademisk; 2013.
28.
Evensen S, Ueland T, Lystad JU, Bull H, Klungsoyr O, Martinsen EW, Falkum E. Employment outcome and predictors of competitive employment at 2-year follow-up of a vocational rehabilitation programme for individuals with schizophrenia in a high-income welfare society. Nord J Psychiatry. 2016:1–8.
29.
Wing JK, Curtis RH, Beevor AS. HoNOS: health of the nation outcome scales: report on Research and Development July 1993–December 1995. London: Royal College of Psychiatrists; 1996.
30.
Helsedirektoratet. In: Divisjon helseøkonomi og finansiering A, DRG fo, editor. Guidelines for economic evaluation in the health sector. Oslo: Helsedirektoratet v/ Trykksaksekspedisjonen; 2012.
31.
StatisticsNorway. Consumer price index, February 2016. Oslo, Norway: Statistics Norway; 2016.
32.
NorgesBank. Annual exchange rates (from 1960). Oslo: Norges Bank; 2016.
33.
Helle S, Gråwe R. Employment and social benefit among persons with schizophrenia in Norway. J Norwegian Psychol Assoc. 2007;44(11):1358–62.
34.
Tandberg M, Ueland T, Sundet K, Haahr U, Joa I, Johannessen JO, Larsen TK, Opjordsmoen S, Rund BR, Rossberg JI, et al. Neurocognition and occupational functioning in patients with first-episode psychosis: a 2-year follow-up study. Psychiatry Res. 2011;188(3):334–42.PubMed
35.
Melle I, Friis S, Hauff E, Vaglum P. Social functioning of patients with schizophrenia in high-income welfare societies. Psychiatr Serv. 2000;51(2):223–8.PubMed
36.
Bobinac A, van Exel J, Rutten FF, Brouwer WB. The value of a QALY: individual willingness to pay for health gains under risk. Pharmacoeconomics. 2014;32(1):75–86.PubMed
37.
IBM: IBM SPSS statistics for windows. 21.0 edn. Armonk, NY: IBM Corp; 2012.
38.
StataCorp. Stata for Windows. College Station: StataCorp LP; 2013.
39.
Kahn I. Design & Analysis of clinical trials for Economic Evaluation & Reimbursement: an applied approach using SAS & STATA. Boca Raton, Florida: CRC Press, Taylor & Francis Group; 2016.
40.
Mihaylova B, Briggs A, O'Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20(8):897–916.PubMed
41.
Drummond MF, Schulpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care Programmes. 4th ed. Oxford: Oxford University Press; 2015.
42.
Sælensminde K: Helseeffekter i samfunnsøkonomiske analyser Edited by Health NDo: Norwegian Directorate of Health; 2007.
43.
Bang H, Zhao H. Cost-effectiveness analysis: a proposal of new reporting standards in statistical analysis. J Biopharm Stat. 2014;24(2):443–60.PubMedPubMedCentral
44.
Bush PW, Drake RE, Xie H, McHugo GJ, Haslett WR. The long-term impact of employment on mental health service use and costs for persons with severe mental illness. Psychiatr Serv. 2009;60(8):1024–31.PubMed
45.
Schneider J, Boyce M, Johnson R, Secker J, Slade J, Grove B, Floyd M. Impact of supported employment on service costs and income of people with mental health needs. J Ment Health. 2009;18(6):533–42.
46.
Perkins DV, Born DL, Raines JA, Galka SW. Program evaluation from an ecological perspective: supported employment services for persons with serious psychiatric disabilities. Psychiatr Rehabil J. 2005;28(3):217–24.PubMed
47.
Reme S, Monstad K, Fyhn T, Øverland S, Ludvigsen K, Sveinsdottir V, Løvvik C, Lie SA: Effektevaluering av Individuell jobbstøtte (IPS). In.: Uni research Helse & Uni research Rokkansenteret; 2016.
48.
Black WC. The cost-effectiveness plane: a graphic representation of cost-effectiveness. Med Decis Mak. 1990;10(3):212–5.
Metadata
Title
Exploring the potential cost-effectiveness of a vocational rehabilitation program for individuals with schizophrenia in a high-income welfare society
Authors
Stig Evensen
Torbjørn Wisløff
June Ullevoldsæter Lystad
Helen Bull
Egil W. Martinsen
Torill Ueland
Erik Falkum
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Schizophrenia
Published in
BMC Psychiatry / Issue 1/2019
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-019-2130-7

Other articles of this Issue 1/2019

BMC Psychiatry 1/2019 Go to the issue

Research article

Daily variation in post traumatic stress symptoms in individuals with and without probable post traumatic stress disorder

Research article

Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study

Study protocol

Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

Case report

Case report: a giant arachnoid cyst masking Alzheimer’s disease

Research article

Comorbid tobacco and other substance use and symptoms of anxiety and depression among hospitalised orthopaedic trauma patients

Research article

An integrated, collaborative healthcare model for the early diagnosis and management of dementia: Preliminary audit results from the first transdisciplinary service integrating family medicine and geriatric psychiatry services to the heart of patients’ homes